The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients.

Zhang, Xiuying; Sun, Haidan; Paul, Sanjoy K; Wang, Quanhui; Lou, Xiaomin; Hou, Guixue; Wen, Bo; Ji, Linong; Liu, Siqi.

Afiliação

Zhang X; Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Centre, No. 11, Xi Zhi Men Nan Da Jie, Xicheng District, Beijing, 100044 China.
Sun H; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101 China.
Paul SK; Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005 China.
Wang Q; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Lou X; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101 China.
Hou G; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101 China.
Wen B; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101 China.
Ji L; Proteomics Division, BGI-Shenzhen, Shenzhen, 518083 China.
Liu S; Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Centre, No. 11, Xi Zhi Men Nan Da Jie, Xicheng District, Beijing, 100044 China.